Bri2 BRICHOS domain inhibits IAPP amyloid formation and improves beta cell function in stem cell-derived islets under metabolic stress

Our findings suggest that the molecular chaperone Bri2 colocalises with IAPP and insulin in SC-islet beta cells. The folding assistance has been ascribed to the BRICHOS domain in Bri2 and viral overexpression of the BRICHOS domain can prevent the formation of cytotoxic IAPP amyloid and improve beta cell function in SC-islets exposed to metabolic stress. A comprehensive analysis of SC-islet functionality excludes beta cell impairment as a cause for amyloid reduction but supports the protection against IAPP amyloid.

Authors

Institutions

Publication Details

Journal
Diabetologia
Published
2025-11-10
DOI
https://doi.org/10.1007/s00125-025-06582-5
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bri2 BRICHOS domain inhibits IAPP amyloid formation and improves beta cell function in stem cell-derived islets under metabolic stress

Robin S. Lindsay, Jing Cen, Svitlana Vasylovska, Joey Lau et al.
Diabetologia
Alzheimer's disease research and treatments
article

Bri2 BRICHOS domain inhibits IAPP amyloid formation and improves beta cell function in stem cell-derived islets under metabolic stress

Robin S. Lindsay, Jing Cen, Svitlana Vasylovska, Joey Lau, Gunilla T. Westermark, Anja Ivis, Kina Adjieva
article en

Abstract

Our findings suggest that the molecular chaperone Bri2 colocalises with IAPP and insulin in SC-islet beta cells. The folding assistance has been ascribed to the BRICHOS domain in Bri2 and viral overexpression of the BRICHOS domain can prevent the formation of cytotoxic IAPP amyloid and improve beta cell function in SC-islets exposed to metabolic stress. A comprehensive analysis of SC-islet functionality excludes beta cell impairment as a cause for amyloid reduction but supports the protection against IAPP amyloid.

DiabetologiaVol. 69(2)
Uppsala University (SE)
Novo Nordisk, Uppsala Universitet, Novo Nordisk Fonden
Openalex Percentile: Top 59%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.